Published: Jan 27, 2021
SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Michael Yang, Executive Vice President and Chief Commercial Officer, will be leaving the organization effective January 29, 2021 to assume the role of chief executive officer at another healthcare company. Charmaine Lykins, Senior Vice President, Global Product Planning and Chief Marketing Officer and Amanda Morgan, Senior Vice President, Chief Revenue and Customer Officer,
will lead the commercial organization.
Charmaine Lykins, Senior Vice President, Global Product Planning and Chief Marketing Officer (Photo: Business Wire)
“On behalf of the entire management team and our employees, I want to thank Michael for his significant contributions and we wish him well in his future endeavors,” said Steve Davis, Chief Executive Officer. “Amanda and Charmaine have been the foundation of our commercial success and I look forward to their continued leadership.”